Global: Early-stage healthcare funding remains focused on diagnostics

Hanyu Medical headquarters

In another steady week for early-stage healthcare funding, diagnostics remains the favoured sub-sector. France’s OncoDiag, a company specialising in the development of diagnostic tests for the early detection of bladder, colorectal and prostate cancer, has raised €2.5m (US$3m) Series A funding. Of this, €1.5m was from several groups of business angels, including a number of…

You must be a HMI Subscriber to view this content.

Subscribe Now »